Based on the latest data from August 2025, Intuitive Surgical (ISRG) is trading at $473.30, positioning the stock in the undervalued zone below the 40.2x PE multiple boundary of $293.73. This represents a significant discount to the company's historical valuation ranges, with the stock trading well below even the most conservative PE threshold. The current price sits substantially below the value zone (40.2x-50.2x PE, $293.73-$366.33), fair value zone (50.2x-60.1x PE, $366.33-$438.99), watch zone (60.1x-70.0x PE, $438.99-$511.59), overvalued zone (70.0x-80.0x PE, $511.59-$584.18), and warning zone (above 80.0x PE, above $584.18). Historically, ISRG has demonstrated significant valuation expansion and contraction cycles throughout the analyzed period. The stock experienced substantial undervaluation during the COVID-19 pandemic in early 2020, trading below $200 and well within undervalued territory. A dramatic revaluation occurred through 2021, with the stock reaching peak valuations above $350 and entering overvalued zones between the 70.0x-80.0x PE multiples. The 2022 market correction brought valuations back to more reasonable levels around $200-270, primarily in the value to fair zones. A notable recovery began in late 2022, with the stock climbing steadily through 2023-2024, reaching new highs above $580 in early 2025 and briefly entering warning zone territory above the 89.9x PE multiple. The recent decline to current levels represents a significant compression from these peak valuations, bringing the stock back to historically attractive entry points below even the most conservative PE boundaries.